A Novel Immunoassay for Palytoxin. Phase 1

Abstract

Phase I was highly successful in meeting its goals. The purpose of this research effort is the development of a novel, non-isotopic immunoassay for the detection of palytoxin. This assay must be sufficiently sensitive, specific and robust to meet the unique demands of field use. Two solid-phase immunoassay approaches were planned for evaluation using: (1) an immobilized antigen surface and (2) an immobilized antibody surface. During Phase I, the immobilized antigen approach was very successful. It attained RIA sensitivity (0.05 pmol) with a one hour assay time. Preliminary results also indicated that the use of unextracted serum did not interfere with the analysis. For feasibility studies on the antibody-coated surface approach, the FLIA has produced comparable sensitivity, but longer assay time at present. Studies using purified antibody are underway and are expected to improve significantly on the preliminary results obtained during the first monthly reporting period. During Phase II, we plan to improve the assay for palytoxin with specific emphasis on developing it as a field test by: developing a qualitative dipstick assay, optimizing the quantitative assay, and applying the FLIA to the palytoxin to maximize the robustness of the method. ...Palytoxin, Immunoassay, Non-Radioactive, Non-Enzymatic, SBIR, BD; RAI.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Feb 15, 1990
Accession Number
ADA259528

Entities

People

  • Chia-ling Hu

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Abstracts
  • Antibodies
  • Biomedical Research
  • Column Chromatography
  • Contracts
  • Department Of Defense
  • Detection
  • Feasibility Studies
  • Field Tests
  • Immune Serums
  • Immunoassay
  • Medical Personnel
  • Proteins
  • Small Business
  • Solid Phases
  • Standards
  • Test And Evaluation

Readers

  • Molecular and Cellular Biochemistry
  • Systems Analysis and Design